EUCTR2011-005989-38-SE进行中（未招募）1 期
A SAFETY AND EFFICACY STUDY OF ADDING LOW DOSE PEGYLATED IFN-ALPHA 2B TO STANDARD DOSE DASATINIB IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA - Nord CML 007
orwegian University of Science and Technology0 个研究点目标入组 22 人开始时间: 2012年8月27日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. CML in chronic phase under TKI treatment in the Nord CML007 study
- •2. Treated with TKI for at least three years and in MR4 for at least one year.
- •3. Typical BCR/ABL1 transcript (b3a2 and/or b2a2) must have been confirmed at diagnosis or later during the disease course.
- •4. 18 years or older.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 5
排除标准
- •1. Previous AP/BC at any time in the history of the disease.
- •2. Current participation in another clinical study.
- •3. Planned allogeneic stem cell transplantation.
研究者
相似试验
进行中（未招募）
1 期
A study of safety and effect of adding a low dose of interferon to dasatinib in patients with newly diagnosed chronic myeloid leukemia (CML)EUCTR2011-005989-38-NOorwegian University of Science and Technology35
进行中（未招募）
1 期
A study of safety and effect of adding a low dose of interferon to dasatinib in patients with newly diagnosed chronic myeloid leukemia (CML)EUCTR2011-005989-38-DKorwegian University of Science and Technology35
进行中（未招募）
不适用
A study of safety and effect of adding a low dose of interferon to dasatinib in patients with newly diagnosed chronic myeloid leukemia (CML)Chronic myeloid leukemiaEUCTR2011-005989-38-FIorwegian University of Science and Technology35
招募中
3 期
Investigation of the Effect of Senagraph on colon preparatioChronic Kidney Disease.Chronic kidney disease (CKD)IRCT20180412039283N2Shahid Beheshti University of Medical Sciences122
已完成
不适用
Evaluation of the safety and efficacy of low dose transgenic rice containing peptides from Japanese cedar pollen allergens.JPRN-UMIN000016078The Jikei University, School of Medicine21